The management of pregnant patients with antiphospholipid syndrome

Lupus

Volumn 13, Issue 9, 2004, Pages 683-687

  Cervera, R ^a,c   Balasch, J ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Aspirin; Heparin; Lupus anticoagulant; Pregnancy loss

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CALCIUM; DALTEPARIN; ENOXAPARIN; HEPARIN; IFETROBAN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PHOSPHOLIPID ANTIBODY; PREDNISONE; REVIPARIN; TINZAPARIN; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; BIRTH DEFECT; BIRTH RATE; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; DRUG CHOICE; FETUS MONITORING; FETUS OUTCOME; FETUS RESORPTION; FETUS WASTAGE; HUMAN; LOW DRUG DOSE; MATERNAL DISEASE; MATERNAL HYPERTENSION; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; PLACENTA CIRCULATION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL GROWTH; PRIORITY JOURNAL; SPINE DISEASE; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS;

ABORTION, HABITUAL; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; FEMALE; HEPARIN; HUMANS; PLATELET AGGREGATION INHIBITORS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 4644254522     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu1092oa     Document Type: Conference Paper

References (34)

1. Balasch J, Carmona J, Creus M, Font J, Cervera R. Management of reproductive failure in the antiphospholipid syndrome. In Asherson RA, Cervera R, Piette JC, Shoenfeld Y eds. The antiphospholipid syndrome. II Autoimmune thrombosis. Amsterdam: Elsevier 2002: 375-394.
2. Fishman P, Falach-Vaknine E, Zigelman R et al. Prevention of fetal loss in experimental anti-phospholipid syndrome by in vitro administration of recombinant interleukin-3. J Clin Invest 1993; 91: 1834-1837.
3. Krause I, Blank M, Gilbrut B, Shoenfeld Y. The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome. Am J Reprod Immunol 1993; 29: 155-161.
4. Shoenfeld Y, Blank M, Shere Y. Induction and treatment of the antiphospholipid syndrome-lessons from animal models. Eur J Clin Invest 2001; 31: 736-740.
5. Cowchock S. Prevention of fetal death in the antiphospholipid antibody syndrome. Lupus 1996; 5: 467-472.
6. Coomarasamy A, Papaioannou S, Gee H, Khan KS. Aspirin for the prevention of preeclampsia in women with abnormal uterine artery doppler: a meta-analysis. Obstet Gynecol 2001; 98: 861-866.
7. Balasch J, Carmona F, Lopez-Soto A et al. Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Reprod 1993; 8: 2234-2239.
8. Carmona F, Font J, Cervera R et al. Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol 1999; 83: 137-142.
9. Carmona F, Font J, Azulay M et al. Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis. Am J Reprod Immunol 2001; 46: 274-279.
10. Silver RK, MacGregor SN, Sholl JS et al. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993; 169: 1411-1417.
11. Lima F, Khamashta MA, Buchanan NMM et al. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996; 14: 131-136.
12. Granger KA, Farquharson RG. Obstetric outcome in antiphospholipid syndrome. Lupus 1997; 6: 509-513.
13. Le Thi Huong D, Wechsler B, Bletry O et al. A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol 2001; 28: 2025-2030.
14. Silveira LH, Hubble CL, Jara LJ et al. Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. Am J Med 1992; 93: 403-411.
15. Ruiz-Irastorza G, Khamashta MA, Hughes GRV. Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome. Lupus 2001; 10: 241-245.
16. Hertz-Picciotto I, Hopenhayn-Rich C, Golub M et al. The risks and benefits of takind aspirin during pregnancy. Epidemiol Rev 1990; 12: 108-148.
17. Ginsberg JS, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 1998; 114: 524S-530S.
18. Botet F, Romera G, Montagut P et al. Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. J Perinat Med 1997; 25: 192-196.
19. Rosove MH, Tabsh K, Wasserstrom N et al. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990; 75: 630-634.
20. Kutteh WH, Rote NS, Silver R. Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. Am J Reprod Immunol 1999; 41: 133-152.
21. Vinatier D, Dufour P, Cosson M et al. Antiphospholipid syndrome and recurrent miscarriage. Eur J Obstet Gynecol 2001; 96: 37-50.
22. Sanson BJ, Lensing AWA, Prins MH et al. Safety of low molecular weight heparin in pregnancy: a systematic review. Thromb Haemost 1999; 81: 668-672.
23. Esplin MS. Management of antiphospholipid syndrome during pregnancy. Clin Obstet Gynecol 2001; 44: 20-28.
24. Khamashta MA. Management of thrombosis and pregnancy loss in the antiphospholipid syndrome. Lupus 1998; 7 (Suppl. 2): S162-S165.
25. Greaves M, Cohen H, Machin SJ, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000; 109: 704-715.
26. Derksen RHW, De Groot PhG, Nieuwenhuis HK et al. How to treat women with antiphospholipid antibodies in pregnancy? Ann Rheum Dis 2001; 60: 1-3.
27. Rai R, Cohen H, Dave M et al. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997; 314: 253-257.
28. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174: 1584-1589.
29. Kingdom J, Jauniaux E. Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. No cytogenetic data were reported. Br Med J 1997; 315: 372.
30. Piette JC, Le Thi Huong D, Wechsler B. During pregnancy, heaprin should be stopped during labour and then restarted sonn after delivery. Br J Med 1997; 315: 372-373.
31. Balasch J, Cervera R. Reflections on the management of reproductive failure in the antiphospholipid syndrome - the clinician's perspective. Lupus 2002; 11: 467-477.
32. Pattison NS, Chamley LW, Birdsall M et al. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 2000; 183: 1008-1012.
33. Kwak JYH, Barini R, Gilman-Sachs A et al. Down-regulation of maternal antiphospholipid antibodies during early pregnancy and pregnancy outcome. Am J Obstet Gynecol 1994; 171: 239-246.
34. Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984; 148: 140-146.